Erectile Dysfunction

Recently some investors have been negative on the pharmaceutical industry, but Pfizer looks good here.

With a market cap of $190 billion, Pfizer is the world's largest research pharmaceutical company, and the company is set to report its quarterly results this Friday.

Analysts expect 57 cents in EPS on a 12.3% increase in sales and a 9.3% increase in profits.

Over the past year, shares have traded in a fairly narrow range, and the stock has been hemmed in by the loss of its patent-protected monopoly on several highly profitable drugs.

In order to address the loss of revenue, management has cut costs by laying off 10,000 workers and closing or selling five plants.

Although the word "layoffs" makes people cringe, they ultimately benefit a corporation's bottom line.

The loss of patents does hurt the company, but it is part of the normal cycle with pharmaceutical researchers and producers.

With its huge free cash flow of nearly $20 billion and its investment into research and development, Pfizer has the capacity to replace lost patents.

In its R&D role, Pfizer is engaging in an important role for society in seeking new solutions to medical ailments, while at the same time boosting its profits.

In ...

Attorney Michael Berger said, "She's going to be shown to be a total liar and a thief." The Manhattan DA's office says they are investigating Caxton Iseman's claims about Monahan, but Monahan's attorney was not available for comment.

Posted by Jen Chung in News: NYC April 17, 2007 9:52 AM Post a comment Are you aware of our Comment Policy?

Name: Email Address: URL: Remember personal info?

Comments: (you may use HTML tags for style, but you can only add links if you've signed in) Preview Your preview will show up here.

Start typing!

*Tags allowed: a href, b, i, br/, p, strong, em, ul, ol, li, blockquote, pre 2003-2007 Gothamist LLC.

All rights reserved.

We use MovableType.

...